Trial intelligence / Profile preview

BHB-1893 Compared to Metoprolol in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy

NCT07755904Phase 3Recruiting

Start
Sep 2026
Primary completion
Oct 2028
Countries
1
01

Overview

A Phase 3 trial of HRS-1893 in Hypertrophic Obstructive Cardiomyopathy (HOCM). Started Sep 2026; status: recruiting.

02

Drugs

HRS-1893
03

Conditions

Hypertrophic Obstructive Cardiomyopathy (HOCM)

Beyond the preview

Go deeper on NCT07755904.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07755904.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call